產(chǎn)品詳情
簡單介紹：
Anti-Prokineticin 1抗體產(chǎn)品質(zhì)量穩(wěn)定，實驗效果明顯，貨期快，價格優(yōu)惠，歡迎垂詢訂購！我公司長期供應**組化抗體、WB抗體、**組化試劑盒和抗體試驗所需全部相關試劑、熒光標記抗體、單克隆抗體、多克隆抗體、各種標記的二抗IgG/IgM/IgD/IgA等科研實驗抗體。Anti-Prokineticin 1抗體用于**組化實驗,WB實驗,相應的標記抗體有HRP標記抗體,FITC標記,BIO等。
詳情介紹：
Rabbit Anti-Prokineticin 1
Cat. Number:
Anti-Prokineticin 1抗體KL-2638R
Quantity size:
0.2ml
Concentration:
1mg/ml Buffer = 0.01M TBS(pH7.4) with 1% BSA, 0.03% Proclin300 and 50% Glycerol.
Background:
The protein encoded by this gene induces proliferation, migration, and fenestration (the formation of membrane discontinuities) in capillary endothelial cells derived from endocrine glands. It has little or no effect on a variety of other Anti-Prokineticin 1抗體endothelial and non-endothelial cell types. Its expression is restricted to the steroidogenic glands (ovary, testis, adrenal, and placenta), is induced by hypoxia, and often complementary to the expression of vascular endothelial growth factor (VEGF), suggesting that these molecules function in a coordinated manner. [provided by RefSeq, Sep 2011]
Also known as:
Prokineticin-1/Endocrine-gland-derived vascular endothelial growth factor; Prokineticin1; Prokineticin 1; EG-VEGF; EG VEGF; Anti-Prokineticin 1抗體EGVEGF; PROK1; EGVEGF; PK1; PRK1; PROK1_HUMAN; Black mamba toxin related protein; Endocrine gland derived vascular endothelial growth factor; Endocrine-gland-derived vascular endothelial growth factor; Mambakine; Prokineticin-1.
Specificity:
●
Rabbit Polyclonal IgG, affinity purified by Protein A.
●
Reacts with: Human, Mouse, Rat, Anti-Prokineticin 1抗體Dog, Pig, Horse, Rabbit, .
●
Immunogen: KLH conjugated synthetic peptide derived from human PROK1 C-terminus.
●
Predicted Molecular Weight: 9.7kDa.
Storage:
Shipped at 4℃, Store at -20℃ (Avoid repeated freeze/thaw cycles).
Application:
WB=1:100-500 ELISA=1:500-1000 IHC-P=1:100-500 IHC-F=1:100-500 IF=1:100-500
Not yet tested in other applications. Anti-Prokineticin 1抗體
Optimal working dilutions must be determined by the end user.
Not yet tested in other applications. Anti-Prokineticin 1抗體
Optimal working dilutions must be determined by the end user.
